RECOMBINANT INTERLEUKIN-2 THERAPY IN SEVERE COMBINED IMMUNODEFICIENCY DISEASE

[1] AIUTI FR, 1986, RECENT ADV PRIMARY A, P155

[2] FUNCTIONAL AND MOLECULAR ASPECTS OF HUMAN LYMPHOCYTE-T ACTIVATION VIA T3-TI-PATHWAYS AND T11-PATHWAYS [J]. IMMUNOLOGICAL REVIEWS, 1987, 95 : 5 - 36

[3] AZOQUI O, 1983, J IMMUNOL, V131, P1205

[4] REQUIREMENT FOR MITOGEN, T-CELL ACCESSORY CELL CONTACT, AND INTERLEUKIN-1 IN THE INDUCTION OF RESTING T-CELL PROLIFERATION [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 44 (02): : 235 - 247

[5] CHATILA TA, 1987, CLIN RES, V35, P613

[6] IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN-1 [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15): : 4945 - 4949

[7] CUNNINGHAMRUNDL.C, 1976, CLIN IMMUNOLOGY, P151

[8] DINARELLO CA, 1986, ANNU REV MED, V37, P173

[9] DOI S, 1988, CLIN IMMUNOL IMMUNOP, V46, P24, DOI 10.1016/0090-1229(88)90003-7

[10] FLOMENBERG N, 1983, J IMMUNOL, V130, P2644

[1] AIUTI FR, 1986, RECENT ADV PRIMARY A, P155

[2] FUNCTIONAL AND MOLECULAR ASPECTS OF HUMAN LYMPHOCYTE-T ACTIVATION VIA T3-TI-PATHWAYS AND T11-PATHWAYS [J]. IMMUNOLOGICAL REVIEWS, 1987, 95 : 5 - 36

[3] AZOQUI O, 1983, J IMMUNOL, V131, P1205

[4] REQUIREMENT FOR MITOGEN, T-CELL ACCESSORY CELL CONTACT, AND INTERLEUKIN-1 IN THE INDUCTION OF RESTING T-CELL PROLIFERATION [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 44 (02): : 235 - 247

[5] CHATILA TA, 1987, CLIN RES, V35, P613

[6] IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN-1 [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15): : 4945 - 4949

[7] CUNNINGHAMRUNDL.C, 1976, CLIN IMMUNOLOGY, P151

[8] DINARELLO CA, 1986, ANNU REV MED, V37, P173

[9] DOI S, 1988, CLIN IMMUNOL IMMUNOP, V46, P24, DOI 10.1016/0090-1229(88)90003-7

[10] FLOMENBERG N, 1983, J IMMUNOL, V130, P2644